PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26177294-0	2016	Fasudil, a clinically safe ROCK inhibitor, decreases disease burden in a Cbl/Cbl-b deficiency-driven murine model of myeloproliferative disorders.	fasudil	0-7	Casitas B-lineage lymphoma b	Mus musculus	77-82	
26177294-4	2016	METHODS: Fasudil exhibited relatively selective anti-proliferative activity against Cbl/Cbl-b DKO vs. control murine bone marrow HSPCs.	fasudil	9-16	Casitas B-lineage lymphoma b	Mus musculus	88-93	
26177294-9	2016	Notably, prolonged survival beyond 27 weeks was observed in two fasudil-treated mice, nearly twice the 16-week average life-span in the Cbl/Cbl-b DKO MPD model.	fasudil	64-71	Casitas B-lineage lymphoma b	Mus musculus	140-145